$DGX Potential breakout ($MRNA $GILD $INO $SPY)
Zaktualizowano
see charts at tradingview.com/u/WallSt007
DGX Entry 109
Target 1 $111
Target 2 $114
Target 3 $122
Why DGX?
FDA Authorizes Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for Emergency Use
With Covid wave 2 on the rise, this could be a huge player.
prnewswire.com/news-releases/fda-authorizes-quest-diagnostics-covid-19-nasal-specimen-self-collection-kit-for-emergency-use-301067186.html
What is DGX?
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, United Kingdom, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
DGX Entry 109Target 1 $111
Target 2 $114
Target 3 $122
Why DGX?
FDA Authorizes Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for Emergency Use
With Covid wave 2 on the rise, this could be a huge player.
prnewswire.com/news-releases/fda-authorizes-quest-diagnostics-covid-19-nasal-specimen-self-collection-kit-for-emergency-use-301067186.html
What is DGX?
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, United Kingdom, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
Komentarz
target 1 & 2 hit. almost target 3.notice there was no stop-loss on this play?
because it was reversal play based on our algorithm x.
made $3400 on this play.
twitter.com/CAMR_Group/status/1278389081018372097/photo/1
If you appreciate my technical analysis and want to check out our
Free Newsletter --> diywallst.com/
Free Newsletter --> diywallst.com/
Wyłączenie odpowiedzialności
Informacje i publikacje przygotowane przez TradingView lub jego użytkowników, prezentowane na tej stronie, nie stanowią rekomendacji ani porad handlowych, inwestycyjnych i finansowych i nie powinny być w ten sposób traktowane ani wykorzystywane. Więcej informacji na ten temat znajdziesz w naszym Regulaminie.